Bladder Cancer,Genitourinary Cancer Real-World Use of Avelumab Maintenance in Advanced UC Patients Dec 14, 2023
Bladder Cancer,Genitourinary Cancer Erdafitinib vs. Pembrolizumab in Advanced UC With FGFR Alterations Dec 14, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Post-immunotherapy Nephrectomy Safety in Advanced RCC Dec 11, 2023
Bladder Cancer,Genitourinary Cancer Nadofaragene Firadenovec Efficacy in BCG-unresponsive NMIBC With CIS Dec 08, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Belzutifan vs. Everolimus in Advanced ccRCC Dec 08, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Combined Efficacy of Belzutifan and Cabozantinib in Advanced ccRCC Dec 07, 2023
Bladder Cancer,Genitourinary Cancer NIVO+ GC Extends Survival in Advanced Urothelial Carcinoma Dec 07, 2023
